MPS Pharma & Medical, Inc. develops and manufactures medical devices to advance healthcare across multiple areas of care. Its 30-year company history began in 1990 as MPS Acacia.
In 2014, MPS Pharma began manufacture of MPS Acacia’s market-leading neonatal intensive care products and had since expanded into multiple successful divisions. These include infusion therapy, cell therapy manufacturing, sterile compounding, and in-home pharmacy, as well as OEM services.
At the end of 2020, MPS Pharma was sold to Innova Medical Group to help bring Covid-19 testing supplies to the US market. In 2021, MPS Pharma was formed by the original 2014 managing team to continue its existing product lines. MPS Pharma, Inc. maintains Class 7 cleanrooms for production in its Brea, California facilities.
Today, MPS Pharma's primary focus is meeting customer requirements for high quality, intuitive products and excellent customer support. Click their logo below to learn more!
